Dave Messina - YC founder turned investor talks TechBio
Ever wondered what Pioneer Fund’s Future of Health Fund is excited about? Want to know how to impress Dave Messina? Are you curious about how different funds communicate and interact?Give a listen to ...
6 Heinä 1h 16min
$HIMS Q2 Results - our take as healthcare venture capitalists
Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. W...
5 Elo 20251h 24min
Investing in Psychedelic BioTech [August 2025 webinar replay]
Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP2025 has been the start of a bull period for psychedelic medicine.Psychedelic Biotechs like GH Research, Compass ...
30 Heinä 202558min
Compass and ATAI latest news + are Psychedelics BACK in 2025?!
The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make...
29 Heinä 202516min
Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field
Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI w...
22 Heinä 20251h 33min
How to start a VC fund
I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThis is a great listen for anyone interested in start...
15 Heinä 20251h 20min
Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]
Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org
12 Heinä 20251h 9min
Designing Novel Brain Drugs with Xylo Bio
Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many of their drug candidates are inspired by naturall...
8 Heinä 20251h
